RT can induce immunogenic cell death (ICD), releasing tumor antigens and damage-associated molecular patterns (DAMPs) such as calreticulin (CRT) and high mobility group box 1 (HMGB1) 4. This evidence concerns the gene HMGB1 and neoplasm.